“Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have access to them under two deals announced Thursday by the Trump administration,” CNN reports.
New York Times: “The Trump administration’s agreements with the drugmakers Novo Nordisk and Eli Lilly would save consumers and the government considerable money on Wegovy, Zepbound and two obesity pills that are expected to win regulatory approval in the coming months.”


?Political Trivia
Eight moments in political history. Put them on a timeline.
Play →
Five senators. Three bills. Can you guess how they all voted?
Play →
Nine Justices. One case. How did they rule?
Play →
Do you have your finger on the pulse of America?
Play →
Four questions a day.
Play →
A new game every day.